BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Carbazilquinone

An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

48+ PubMed studies analyzed · 3 RCTs · Evidence Score: 31.8

Research Domains

Carbazilquinone has been studied across 10 research domains including 🔬 Oncology, 🫁 Liver & Detox, ⏳ Longevity & Aging, 🫘 Kidney, 🧬 Hormones. The primary research focus is 🔬 Oncology with 88% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Carbazilquinone, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dinitrochlorobenzene
14 shared targets
Lanatosides
9 shared targets
clofilium
11 shared targets
Methylnitronitrosoguanidine
6 shared targets
acivicin
5 shared targets
Quinestrol
8 shared targets
Tubercidin
9 shared targets
Tomatine
5 shared targets
Clofarabine
9 shared targets
pyrrolnitrin
5 shared targets
Loading evidence profile...

This evidence profile for Carbazilquinone is generated deterministically from 48 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.